LIfT BioSciences ^Companies

LIfT BioSciences is a biotech company based in London, England, that is focused on developing affordable curative cell therapies for solid tumors with high unmet medical need. They have a breakthrough allogeneic innate immuno-cell therapy platform called N-LIfT that allows them to produce Immunomodulatory Alpha Neutrophils (IMANs) at scale from iPSCs. These IMANs have a unique dual mechanism-of-action that directly kills cancer cells and recruits and modulates the rest of the immune system to identify and destroy tumors. LIfT BioSciences has received recognition for their innovative approach, including being awarded an Innovate UK Grant and having abstract publications at the American Society of Clinical Oncology (ASCO) Annual Meeting.